The YRC is a NIGMS Biomedical Technology Research Center based at the University of Washington in Seattle. Click to learn more about us.
Learn more about the technologies being developed by the YRC and how they are being applied to biomedical problems.
Collaborators Since 2011
Annual NIH Dollars Impacted
We are developing technology to produce biosensors based on a ligand-binding domain (LBD) that may, in principle, be applied to any target molecule. The power of this method is illustrated in this paper by development of biosensors for digoxin and progesterone.
In this work, we combine the results of protein cross-linking mass spectrometry with iterative structural modelling to determine the molecular architecture of the 10-member Dam1p protein complex in S. cerevisiae. Using this technique, we can model conformational changes resulting from binding with microtubules.
Shah, SH et al. (2022) Quantitative BONCAT Allows Identification of Newly Synthesized Proteins after Optic Nerve Injury. J Neurosci 42 (19):4042-4052. PubMed PMID:35396330
Hills, E et al. (2022) Comprehensive Mutational Analysis of the Lasso Peptide Klebsidin. ACS Chem Biol 17 (4):998-1010. PubMed PMID:35315272
Shah, SH et al. (2022) Quantitative transportomics identifies Kif5a as a major regulator of neurodegeneration. Elife 11 :. PubMed PMID:35259089
Plubell, DL et al. (2022) Putting Humpty Dumpty Back Together Again: What Does Protein Quantification Mean in Bottom-Up Proteomics?. J Proteome Res 21 (4):891-898. PubMed PMID:35220718
Stillman, M et al. (2022) Activity dependent dissociation of the Homer1 interactome. Sci Rep 12 (1):3207. PubMed PMID:35217690